Innoforce gets $96M to build up China campus, including a new Thermo Fisher-partnered monoclonal antibody manufacturing facility
Several months after completing what it calls a “Pre-A” financing round, Chinese contract manufacturer Innoforce Pharmaceuticals is back at the venture well, drawing $96 million …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.